BioSpace News Archive

Heska Corporation, a leading provider of advanced veterinary diagnostic and specialty products, will report its third quarter 2021 financial performance in a press release before the market opens on Thursday, November 4, 2021.

SOFIE Biosciences (SOFIE), an established US manufacturer and developer of radiopharmaceuticals, achieves a major milestone with the filing of an IND application to the FDA for a radiopharmaceutical targeting Fibroblast Activation Protein Inhibitor (FAPI).

IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) (“IceCure” or the “Company”), today announced the advancement of its regulatory strategy in China with the submission of an amendment to the registration certificate for the IceSense3® system, which was granted by China’s National Medical Products Administration (“NMPA”).

INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases, today announced the online preprint publication in MedRxiv of Phase 1 clinical data on homologous boosting of its COVID-19 DNA vaccine candidate, INO-4800.

Patients diagnosed with a rare cancer called Epithelioid Sarcoma face many challenges that will impact their outcome, beginning with the lengthy timeframe between presentation of the disease and a confident diagnosis to ultimately finding access to proper treatment and care through a sarcoma specialist.

The brain mapping research along with the investigation projects, as well as the technological developments in tools and algorithms that are being implemented in neuroscience space are among the primary factors contributing to the progress of the global neuroscience market.

Histopathology can be defined as the examination of various diseases that are liked to tissues. Conducted with the help of microscopes, products in the global histopathology testing equipment market examine the characteristics of these diseases.

The emergence of sensor technology and continuous advancements in the technology play a pivotal role in the growth of the global market for disposable medical sensors.

Growth in the prevalence of sport-related injuries across major parts of the globe is anticipated to drive demand opportunities in the global ACL reconstruction market during the forecast period of 2021 to 2031.

GenSight Biologics, a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, announced that the U.S. Food & Drug Administration has granted Fast Track Designation to GS030, which combines AAV2-based gene therapy with optogenetics to treat Retinitis Pigmentosa.